 | Up a level |
Journal Article
Cooper, Jason P., Storer, Barry E., Granot, Noa, Gyurkocza, Boglarka, Sorror, Mohamed L., Chauncey, Thomas R., Shizuru, Judith, Franke, Georg-Nikolaus, Maris, Michael B., Boyer, Michael, Bruno, Benedetto, Sahebi, Firoozeh, Langston, Amelia A., Hari, Parameswaran, Agura, Edward D., Petersen, Soren Lykke, Maziarz, Richard T., Bethge, Wolfgang, Asch, Julie, Gutman, Jonathan A., Olesen, Gitte, Yeager, Andrew M., Hubel, Kai, Hogan, William J., Maloney, David G., Mielcarek, Marco, Martin, Paul J., Flowers, Mary E. D., Georges, George E., Woolfrey, Ann E., Deeg, H. Joachim, Scott, Bart L., McDonald, George B., Storb, Rainer and Sandmaier, Brenda M. (2021). Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades. Haematologica, 106 (6). S. 1599 - 1608. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Kornblit, Brian, Maloney, David G., Storer, Barry E., Maris, Michael B., Vindelov, Lars, Hari, Parameswaran 
ORCID: 0000-0002-8800-297X, Langston, Amelia A., Pulsipher, Michael A., Bethge, Wolfgang A., Chauncey, Thomas R., Lange, Thoralf, Petersen, Finn B., Huebel, Kai, Woolfrey, Ann E., Flowers, Mary E. D., Storb, Rainer and Sandmaier, Brenda M.
(2014).
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
Haematologica, 99 (10).
S. 1624 - 1632.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078
Sorror, Mohamed L., Sandmaier, Brenda M., Storer, Barry E., Chauncey, Thomas, Shizuru, Judith A., Franke, Georg-Nikolaus, Pulsipher, Michael A., Maris, Michael B., Bruno, Benedetto, Andersen, Niels Smedegaard, Hari, Parameswaran, Langston, Amelia A., Sahebi, Firoozeh, Maziarz, Richard T., Petersen, Finn Bo, Bethge, Wolfgang, Gutman, Jonathan A., Olesen, Gitte, Yeager, Andrew, Huebel, Kai, Hogan, William J., Mielcarek, Marco B., Georges, George E., Maloney, David G. and Storb, Rainer (2017). Allogeneic Hematopoietic Cell Transplantation (HCT) in the Eighth Decade of Life: How Much Does Age Matter? Biol. Blood Marrow Transplant., 23 (3). S. S85 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536
Sorror, Mohamed L., Sandmaier, Brenda M., Storer, Barry E., Franke, Georg N., Laport, Ginna G., Chauncey, Thomas R., Agura, Edward, Maziarz, Richard T., Langston, Amelia, Hari, Parameswaran ORCID: 0000-0002-8800-297X, Pulsipher, Michael A., Bethge, Wolfgang, Sahebi, Firoozeh, Bruno, Benedetto ORCID: 0000-0002-7299-6770, Maris, Michael B., Yeager, Andrew, Petersen, Finn Bo, Vindelov, Lars, McSweeney, Peter A., Huebel, Kai, Mielcarek, Marco, Georges, George E., Niederwieser, Dietger, Blume, Karl G., Maloney, David G. and Storb, Rainer
(2011).
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies.
JAMA-J. Am. Med. Assoc., 306 (17).
S. 1874 - 1884.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 1538-3598